Aims and scope
The only open access journal in its field, Skeletal Muscle publishes novel, cutting-edge research and technological advancements that investigate the molecular mechanisms underlying the biology of skeletal muscle. Reflecting the breadth of research in this area, the journal welcomes manuscripts about the development, metabolism, the regulation of mass and function, aging, degeneration, dystrophy and regeneration of skeletal muscle, with an emphasis on understanding adult skeletal muscle, its maintenance, and its interactions with non-muscle cell types and regulatory modulators.
Main areas of interest include:
- differentiation of skeletal muscle
- atrophy and hypertrophy of skeletal muscle
- aging of skeletal muscle
- regeneration and degeneration of skeletal muscle
- biology of satellite and satellite-like cells
- dystrophic degeneration of skeletal muscle
- energy and glucose homeostasis in skeletal muscle
- non-dystrophic genetic diseases of skeletal muscle, such as Spinal Muscular Atrophy and myopathies
- maintenance of neuromuscular junctions
- roles of ryanodine receptors and calcium signaling in skeletal muscle
- roles of nuclear receptors in skeletal muscle
- roles of GPCRs and GPCR signaling in skeletal muscle
- other relevant aspects of skeletal muscle biology
In addition, articles on translational clinical studies that address molecular and cellular mechanisms of skeletal muscle will be published. Case reports are also encouraged for submission.
Skeletal Muscle reflects the breadth of research on skeletal muscle and bridges gaps between diverse areas of science for example cardiac cell biology and neurobiology, which share common features with respect to cell differentiation, excitatory membranes, cell-cell communication, and maintenance. Suitable articles are model and mechanism-driven, and apply statistical principles where appropriate; purely descriptive studies are of lesser interest.
All articles published by Skeletal Muscle are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Skeletal Muscle you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Skeletal Muscle therefore levies an article-processing charge of £1570.00/$2290.00/€1870.00 for each article accepted for publication, plus VAT or local taxes where applicable.
If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
BMC provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
All articles published in Skeletal Muscle are included in:
- Google Scholar
- PubMed Central
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
Skeletal Muscle operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.
Edited by Kevin P Campbell, David J Glass and Michael A Rudnicki, Skeletal Muscle is supported by an expert Editorial Board.
All manuscripts submitted to Skeletal Muscle should adhere to BioMed Central's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Citing articles in Skeletal Muscle
Articles in Skeletal Muscle should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Skeletal Muscle [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Skeletal Muscle 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Appeals and complaints
If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure. For complaints that cannot be resolved with the Editor, the authors should contact the Publisher.
Why publish your article in Skeletal Muscle
Skeletal Muscle's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
Skeletal Muscle offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Online publication in Skeletal Muscle gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Skeletal Muscle are included in article alerts and regular email updates. Some may be highlighted on Skeletal Muscle’s pages and on the BioMed Central homepage.
In addition, articles published in Skeletal Muscle may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Skeletal Muscle. A list of articles recently press-released by journals published by BioMed Central is available here.
As an author of an article published in Skeletal Muscle you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BioMed Central license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.
Annual Journal Metrics
42 days to first decision for reviewed manuscripts only
34 days to first decision for all manuscripts
114 days from submission to acceptance
19 days from acceptance to publication
527 Altmetric mentions